{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:20:46Z","timestamp":1784254846894,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,3]]},"DOI":"10.7759\/cureus.49859","type":"journal-article","created":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T10:09:01Z","timestamp":1701598141000},"source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of In-Vitro Activity of Ceftaroline Against Methicillin-Resistant Staphylococcus aureus Clinical Isolates"],"prefix":"10.7759","author":[{"given":"Ankita","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Poddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumudini","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basanti","family":"Pathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subham Ravi","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshni","family":"Dandapat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok  K","family":"Praharaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Raj Kumar","family":"Patro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong SY","year":"2015","unstructured":"Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015, 28:603-61. 10.1128\/CMR.00134-14","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0057-2018","article-title":"Antibiotic resistance and the MRSA problem","volume":"7","author":"Vestergaard M","year":"2019","unstructured":"Vestergaard M, Frees D, Ingmer H. Antibiotic resistance and the MRSA problem. Microbiol Spectr. 2019, 7:10.1128\/microbiolspec.GPP3-0057-2018","journal-title":"Microbiol Spectr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0117-2023","article-title":"Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia","volume":"32","author":"Torres A","year":"2023","unstructured":"Torres A, Kuraieva A, Stone GG, Cill\u00f3niz C. Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur Respir Rev. 2023, 32:10.1183\/16000617.0117-2023","journal-title":"Eur Respir Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-060614-034516","article-title":"Mechanisms of methicillin resistance in Staphylococcus aureus","volume":"84","author":"Peacock SJ","year":"2015","unstructured":"Peacock SJ, Paterson GK. Mechanisms of methicillin resistance in Staphylococcus aureus. Annu Rev Biochem. 2015, 84:577-601. 10.1146\/annurev-biochem-060614-034516","journal-title":"Annu Rev Biochem"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.08.012","article-title":"Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults","volume":"54","author":"Welte T","year":"2019","unstructured":"Welte T, Kantecki M, Stone GG, Hammond J. Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults. Int J Antimicrob Agents. 2019, 54:410-22. 10.1016\/j.ijantimicag.2019.08.012","journal-title":"Int J Antimicrob Agents"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2021.08.003","article-title":"In vitro activity of ceftaroline and other antimicrobial agents against Gram positive bacterial isolates: descriptive study from a university hospital","volume":"40","author":"Siddiqui T","year":"2022","unstructured":"Siddiqui T, Sahu C, Patel SS. In vitro activity of ceftaroline and other antimicrobial agents against Gram positive bacterial isolates: descriptive study from a university hospital. Indian J Med Microbiol. 2022, 40:101-4. 10.1016\/j.ijmmb.2021.08.003","journal-title":"Indian J Med Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr095","article-title":"Ceftaroline fosamil: a new broad-spectrum cephalosporin","volume":"66 Suppl 3","author":"Laudano JB","year":"2011","unstructured":"Laudano JB. Ceftaroline fosamil: a new broad-spectrum cephalosporin. J Antimicrob Chemother. 2011, 66 Suppl 3:iii11-8. 10.1093\/jac\/dkr095","journal-title":"J Antimicrob Chemother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S226649","article-title":"In vitro activity of ceftaroline and comparators against Staphylococcus aureus isolates: results from 6 years of the Atlas program (2012 to 2017)","volume":"12","author":"Zhang Z","year":"2019","unstructured":"Zhang Z, Chen M, Yu Y, Liu B, Liu Y. In vitro activity of ceftaroline and comparators against Staphylococcus aureus isolates: results from 6 years of the Atlas program (2012 to 2017). Infect Drug Resist. 2019, 12:3349-58. 10.2147\/IDR.S226649","journal-title":"Infect Drug Resist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.158612","article-title":"In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus isolates","volume":"33","author":"Basireddy S","year":"2015","unstructured":"Basireddy S, Singh M, Ali S, Kabra V. In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus isolates. Indian J Med Microbiol. 2015, 33:464-5. 10.4103\/0255-0857.158612","journal-title":"Indian J Med Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.7196","article-title":"Comparative in-vitro activity of ceftaroline against Staphylococcus aureus isolates from India","volume":"10","author":"Bakthavatchalam YD","year":"2016","unstructured":"Bakthavatchalam YD, Pragasam AK, Anandan S, et al.. Comparative in-vitro activity of ceftaroline against Staphylococcus aureus isolates from India. J Infect Dev Ctries. 2016, 10:109-12. 10.3855\/jidc.7196","journal-title":"J Infect Dev Ctries"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ576","article-title":"Gender differences in rates of carriage and bloodstream infection caused by methicillin-resistant Staphylococcus aureus: are they real, do they matter and why?","volume":"61","author":"Humphreys H","year":"2015","unstructured":"Humphreys H, Fitzpatick F, Harvey BJ. Gender differences in rates of carriage and bloodstream infection caused by methicillin-resistant Staphylococcus aureus: are they real, do they matter and why?. Clin Infect Dis. 2015, 61:1708-14. 10.1093\/cid\/civ576","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8321834","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA): prevalence and antimicrobial sensitivity pattern among patients-a multicenter study in Asmara, Eritrea","volume":"2019","author":"Garoy EY","year":"2019","unstructured":"Garoy EY, Gebreab YB, Achila OO, et al.. Methicillin-resistant Staphylococcus aureus (MRSA): prevalence and antimicrobial sensitivity pattern among patients-a multicenter study in Asmara, Eritrea. Can J Infect Dis Med Microbiol. 2019, 2019:8321834. 10.1155\/2019\/8321834","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant S. aureus infections among patients in the emergency department","volume":"355","author":"Moran GJ","year":"2006","unstructured":"Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006, 355:666-74. 10.1056\/NEJMoa055356","journal-title":"N Engl J Med"},{"key":"ref14","article-title":"Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh","volume":"21","author":"Anupurba S","year":"2003","unstructured":"Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM. Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol. 2003, 21:49-51.","journal-title":"Indian J Med Microbiol"},{"key":"ref15","article-title":"Detection of inducible clindamycin resistance in clinical isolates of Staphylococcus aureus by the disc diffusion induction test","volume":"5","author":"Shantala GB","year":"2011","unstructured":"Shantala GB, Shetty AS, Rahul Rao K, et al.. Detection of inducible clindamycin resistance in clinical isolates of Staphylococcus aureus by the disc diffusion induction test.  J Clin Diagn Res. 2011, 5:35-7.","journal-title":"J Clin Diagn Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/idr.s4105","article-title":"High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India","volume":"1","author":"Tiwari HK","year":"2008","unstructured":"Tiwari HK, Sapkota D, Sen MR. High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India. Infect Drug Resist. 2008, 1:57-61. 10.2147\/idr.s4105","journal-title":"Infect Drug Resist"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr024","article-title":"Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study","volume":"66","author":"Song JH","year":"2011","unstructured":"Song JH, Hsueh PR, Chung DR, et al.. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother. 2011, 66:1061-9. 10.1093\/jac\/dkr024","journal-title":"J Antimicrob Chemother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3201\/eid1106.040831","article-title":"Methicillin-resistant-Staphylococcus aureus hospitalizations, United States","volume":"11","author":"Kuehnert MJ","year":"2005","unstructured":"Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis. 2005, 11:868-72. 10.3201\/eid1106.040831","journal-title":"Emerg Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1801-3","article-title":"Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment","volume":"21","author":"Hassoun A","year":"2017","unstructured":"Hassoun A, Linden PK, Friedman B. Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment. Crit Care. 2017, 21:211. 10.1186\/s13054-017-1801-3","journal-title":"Crit Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5588\/pha.21.0042","article-title":"Prevalence of methicillin-resistant Staphylococcus aureus in a tertiary hospital in Nepal","volume":"11","author":"Pradhan P","year":"2021","unstructured":"Pradhan P, Rajbhandari P, Nagaraja SB, Shrestha P, Grigoryan R, Satyanarayana S, Davtyan H. Prevalence of methicillin-resistant Staphylococcus aureus in a tertiary hospital in Nepal. Public Health Action. 2021, 11:46-51. 10.5588\/pha.21.0042","journal-title":"Public Health Action"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.77289","article-title":"Methicillin-resistant Staphylococcus aureus: prevalence and current susceptibility pattern in Sikkim","volume":"3","author":"Tsering DC","year":"2011","unstructured":"Tsering DC, Pal R, Kar S. Methicillin-resistant Staphylococcus aureus: prevalence and current susceptibility pattern in Sikkim. J Glob Infect Dis. 2011, 3:9-13. 10.4103\/0974-777X.77289","journal-title":"J Glob Infect Dis"},{"key":"ref22","article-title":"Methicillin resistant Staphylococcus aureus (MRSA) in India: prevalence & susceptibility pattern","volume":"137","author":"Joshi S","year":"2013","unstructured":"Joshi S, Ray P, Manchanda V, et al.. Methicillin resistant Staphylococcus aureus (MRSA) in India: prevalence & susceptibility pattern. Indian J Med Res. 2013, 137:363-9.","journal-title":"Indian J Med Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-23337","article-title":"Methicillin-resistant Staphylococcus aureus in intensive care unit setting of India: a review of clinical burden, patterns of prevalence, preventive measures, and future strategies","volume":"24","author":"Mehta Y","year":"2020","unstructured":"Mehta Y, Hegde A, Pande R, et al.. Methicillin-resistant Staphylococcus aureus in intensive care unit setting of India: a review of clinical burden, patterns of prevalence, preventive measures, and future strategies. Indian J Crit Care Med. 2020, 24:55-62. 10.5005\/jp-journals-10071-23337","journal-title":"Indian J Crit Care Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1527_20","article-title":"Prevalence pattern of MRSA from a rural medical college of North India: a cause of concern","volume":"10","author":"Lohan K","year":"2021","unstructured":"Lohan K, Sangwan J, Mane P, Lathwal S. Prevalence pattern of MRSA from a rural medical college of North India: a cause of concern. J Family Med Prim Care. 2021, 10:752-7. 10.4103\/jfmpc.jfmpc_1527_20","journal-title":"J Family Med Prim Care"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.191798","article-title":"In vitro activity of ceftaroline: a novel antibiotic against methicillin-resistant Staphylococcus aureus","volume":"59","author":"Gaikwad V","year":"2016","unstructured":"Gaikwad V, Gohel T, Panickar S, Chincholkar V, Mangalkar S. In vitro activity of ceftaroline: a novel antibiotic against methicillin-resistant Staphylococcus aureus. Indian J Pathol Microbiol. 2016, 59:496-8. 10.4103\/0377-4929.191798","journal-title":"Indian J Pathol Microbiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2021\/46121.14442","article-title":"Susceptibility of clinical isolates of Staphylococcus aureus to ceftaroline","volume":"15","author":"Sreedharan H","year":"2021","unstructured":"Sreedharan H, Pai KA. Susceptibility of clinical isolates of Staphylococcus aureus to ceftaroline. J Clin Diagn Res. 2021, 15:10-3. 10.7860\/JCDR\/2021\/46121.14442","journal-title":"J Clin Diagn Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00485-18","article-title":"Ceftaroline resistance by clone-specific polymorphism in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus","volume":"62","author":"Lee H","year":"2018","unstructured":"Lee H, Yoon EJ, Kim D, et al.. Ceftaroline resistance by clone-specific polymorphism in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2018, 62:00485-18. 10.1128\/AAC.00485-18","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12081237","article-title":"In vitro activity of ceftaroline and comparators against bacterial isolates collected globally from patients with skin and soft tissue infections: ATLAS program 2019-2020","volume":"12","author":"Kuraieva A","year":"2023","unstructured":"Kuraieva A, Cabezas-Camarero G, Kiratisin P, Utt E. In vitro activity of ceftaroline and comparators against bacterial isolates collected globally from patients with skin and soft tissue infections: ATLAS program 2019-2020. Antibiotics (Basel). 2023, 12:1237. 10.3390\/antibiotics12081237","journal-title":"Antibiotics (Basel)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01833-15","article-title":"In vitro activity of ceftaroline against Staphylococcus aureus isolates collected in 2012 from Latin American countries as part of the AWARE surveillance program","volume":"59","author":"Biedenbach DJ","year":"2015","unstructured":"Biedenbach DJ, Hoban DJ, Reiszner E, et al.. In vitro activity of ceftaroline against Staphylococcus aureus isolates collected in 2012 from Latin American countries as part of the AWARE surveillance program. Antimicrob Agents Chemother. 2015, 59:7873-7. 10.1128\/AAC.01833-15","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106538","article-title":"MRSA surveillance programmes worldwide: moving towards a harmonised international approach","volume":"59","author":"Baede VO","year":"2022","unstructured":"Baede VO, David MZ, Andrasevic AT, et al.. MRSA surveillance programmes worldwide: moving towards a harmonised international approach. Int J Antimicrob Agents. 2022, 59:106538. 10.1016\/j.ijantimicag.2022.106538","journal-title":"Int J Antimicrob Agents"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/208346-evaluation-of-in-vitro-activity-of-ceftaroline-against-methicillin-resistant-staphylococcus-aureus-clinical-isolates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:45Z","timestamp":1707509505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/208346-evaluation-of-in-vitro-activity-of-ceftaroline-against-methicillin-resistant-staphylococcus-aureus-clinical-isolates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,3]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.49859","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,3]]}}}